SignalXSignalX

CDNA CareDx, Inc.

Q3 2025 10-Q
Filed: Nov 4, 2025Period ending Sep 30, 2025
Health Care
Services-Medical LaboratoriesSEC EDGAR
CareDx, Inc. Overview

CareDx, Inc. (CDNA) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 4, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • New risk: Proposed MolDX draft LCD (July 17, 2025) may impose coverage criteria, utilization limits, bundled payments, risking reduced reimbursement
  • • Regulatory risk: Medicare reimbursement under new CPT code 0540U subject to repricing; potential $88 rate cut for AlloSure Kidney starting Jan 2026
+3 more insights

Get deeper insights on CareDx, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.